ITCMDBv1
Clinical TrialID 4975

Clinical and Imaging Trial of Uridine for Veterans With Suicidal Ideation

NCT03265964

Suicidal Ideation

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final clinical_trial record.

Clinical Trial Id
4975
Evidence Id
4975
Core Evidence Id
4975
Source Clinical Trial Id
4955
Herb2 Clinical Trial Id
HBCT004955
Nct Id
NCT03265964
Title
Clinical and Imaging Trial of Uridine for Veterans With Suicidal Ideation
Status
Completed
Phase
Phase 4
Study Result
No
Study Condition
Suicidal Ideation
Study Type
Interventional
Study Design
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT
Intervention
DRUG: Uridine|DRUG: Placebo
Intervention Allocation
Randomized
Intervention Model
Parallel
Intervention Mask
Triple
Intervention Purpose
Treatment
Gender
All
Age
Adult
Enrollment
75
Outcome Measure
Change from Baseline in Columbia-Suicide Severity Rating Scale (C-SSRS), The hypothesis is that 4 weeks of uridine 2000 mg daily will decrease the probability and severity of suicidal ideation measured with the C-SSRS, compared with placebo., 4 weeks
Sponsor Collaborator
VA Office of Research and Development
Funded By
FED
Location
VA Salt Lake City Health Care System, Salt Lake City, UT, Salt Lake City, Utah, 84148-0001, United States
Other Id
MHBB-012-16F|00100075
Start Date
2018-04-02
Primary Completion Date
2024-06-30
Completion Date
2024-06-30
First Posted
2017-08-29
Results First Posted
Last Update Posted
2024-07-30
Study Document
Study Url
https://clinicaltrials.gov/study/NCT03265964
Title Cn
Title En
Clinical and Imaging Trial of Uridine for Veterans With Suicidal Ideation
Bilingual Status
semi_complete